Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.
Amyloid A (AA) amyloidosis is characterized by extracellular pathogenic deposition of insoluble fibril protein in various body organs. Deposited amyloid generally remains in a variety of organs for long periods, but its disappearance has been reported after the precursor protein is diminished. The kinetics of AA deposition are not completely understood and, in particular, the roles of cells and cytokines in the deposition and clearance of amyloid remain unclear. In this study, we investigated the disappearance of amyloid depositions in mice over a 1-year period. AA amyloidosis was induced experimentally in mice by injecting amyloid-enhancing factor (AEF) and silver nitrate. Mice were killed at different time-points to examine the occurrence and disappearance of amyloid depositions. Maximum levels of amyloid depositions were observed at 20 days after inoculation. Clearance of amyloid depositions was observed from the 40th day onwards, with only minute traces of amyloid present by 240 days. A second inflammatory stimulus consisting of AEF and silver nitrate was given at 330 or 430 days, after amyloid depositions had disappeared almost completely. After that, serum amyloid A was overproduced and redeposition of amyloid was observed, indicating that all mice were primed for aggressive amyloid depositions. After administration of the inflammatory stimuli, the proinflammatory environment was found to have increased levels of interleukin (IL)-6, while anti-inflammatory conditions were established by IL-10 as regression of amyloid deposition occurred. These results suggest that the proinflammatory and anti-inflammatory status have key roles in both amyloid deposition and clearance.
United Graduate School of Veterinary Sciences, Laboratory of Food and Environmental Hygiene, Department of Veterinary Medicine, Gifu University, Gifu, Japan.
N
N
Muhammad
United Graduate School of Veterinary Sciences, Laboratory of Food and Environmental Hygiene, Department of Veterinary Medicine, Gifu University, Gifu, Japan.|Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, Tokyo, Japan.
T
T
Murakami
United Graduate School of Veterinary Sciences, Laboratory of Food and Environmental Hygiene, Department of Veterinary Medicine, Gifu University, Gifu, Japan.
Y
Y
Inoshima
United Graduate School of Veterinary Sciences, Laboratory of Food and Environmental Hygiene, Department of Veterinary Medicine, Gifu University, Gifu, Japan.
N
N
Ishiguro
D000686:Amyloidosis / Q000473:pathology*; D000818:Animals; D004195:Disease Models, Animal; D006023:Glycoproteins / Q000008:administration & dosage; D007249:Inflammation / Q000276:immunology; D016753:Interleukin-10 / Q000378:metabolism*; D015850:Interleukin-6 / Q000378:metabolism*; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D058225:Plaque, Amyloid / Q000473:pathology*; D000685:Serum Amyloid A Protein / Q000378:metabolism / Q000493:pharmacokinetics*; D012835:Silver Nitrate / Q000008:administration & dosage; D013154:Spleen / Q000473:pathology
D006023:Glycoproteins; C556062:IL10 protein, mouse; D015850:Interleukin-6; D000685:Serum Amyloid A Protein; C046748:amyloid enhancing factor; D016753:Interleukin-10; D012835:Silver Nitrate
AA-amyloid; SAA; cytokine; long-term kinetics; mice